Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma
Clinical trial NCT03942653 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03942653
- Sponsor
- Manish Patel
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2026-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.